A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 31/4045 (2006.01) A61P 35/00 (2006.01)
Patent
CA 2684114
The invention relates to the use of an HDAC inhibitor, more specifically or a pharmaceutically acceptable salt thereof for the manufacture of pharmaceutical compositions for the treatment of melanoma; the use of an HDAC inhibitor or a pharmaceutically acceptable salt thereof in the treatment of melanoma; a method of treating warm-blooded animals including mammals, especially humans, suffering from melanoma by administering to a said animal in need of such treatment a dose effective against said disease of an HDAC inhibitor or a pharmaceutically acceptable salt thereof.
L'invention concerne l'utilisation d'un inhibiteur HDAC, plus spécifiquement, ou d'un sel pharmaceutiquement acceptable de celui-ci pour la fabrication de compositions pharmaceutiques pour le traitement du mélanome ; l'utilisation d'un inhibiteur HDAC ou d'un sel pharmaceutiquement acceptable de celui-ci dans le traitement du mélanome ; un procédé de traitement d'animaux à sang chaud, mammifères inclus, particulièrement d'humains, souffrant du mélanome, par administration à l'animal nécessitant un tel traitement d'une dose efficace contre la maladie d'un inhibiteur HDAC ou d'un sel pharmaceutiquement acceptable de celui-ci.
Fetherstonhaugh & Co.
Novartis Ag
LandOfFree
Use of hdac inhibitors for the treatment of melanoma does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Use of hdac inhibitors for the treatment of melanoma, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of hdac inhibitors for the treatment of melanoma will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1956046